AORT
Artivion, Inc.
Medical Devices · Healthcare · United States
23.44
close · 2026-10-29
value
29
cheaper than peers29
quality
75
stronger fundamentals75
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 2.81× | 53 |
| price to book | 2.56× | 53 |
| earnings yield, latest year | 0.7% | 50 |
| earnings yield, 2 years ago | -2.6% | 50 |
| earnings yield, 1 year ago | -1.1% | 41 |
| cash flow yield, 3 years ago | -1.1% | 41 |
| cash flow yield, 2 years ago | 0.6% | 32 |
| earnings yield, 3 years ago | -1.6% | 32 |
| forward P/E | 31.32× | 30 |
| cash flow yield, latest year | 0.1% | 23 |
| cash flow yield, 1 year ago | 0.8% | 23 |
| EV to EBITDA | 23.98× | 18 |
12 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | 3.1% | 72 |
| revenue growth | 17.5% | 70 |
| operating margin | 5.2% | 66 |
| debt to equity | 57.3% | 47 |
4 of 4 measures available
Facts
| market cap | $1B |
| free cash flow | -$7.3M |
| employees | 1,800 |
| first trade | 1993-02-12 |
| next earnings | 2026-11-05 |
| fundamentals updated | 2026-08-06 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 0.21 | -0.32 | -0.75 | -0.48 |
| free cash flow | $839,000 | $11.0M | $9.1M | -$15.9M |
| net income | $9.8M | -$13.4M | -$30.7M | -$19.2M |
| revenue | $441.3M | $388.5M | $354.0M | $313.8M |
| unusual items | $4.3M | -$3.7M | $14.3M | $0 |